Drug Trial Radar · NCT00520286
Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence
Last checked: Nov 19, 2026Latest source record: Apr 7, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
210
Actual
Start
Dec 2007
Primary completion
Dec 2009
Study completion Mar 2010
Sponsor
- Lead sponsor
- National Institute on Drug Abuse (NIDA)NIH
- Sponsor type
- NIH
- Collaborators
- VA Office of Research and Development
- First posted
- Aug 24, 2007
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study will be to examine the safety and efficacy of modafinil in increasing number of methamphetamine non-use weeks in subjects with methamphetamine dependence.
Conditions
- Methamphetamine Dependence
Interventions
ModafinilDrug
200 mg or 400 mg /daily
PlaceboDrug
Placebo / daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Abstinence (Week 1 - 12)Time frame: Weeks 1 - 12
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
South Bay Treatment Center
San Diego, California
Matrix Institute on Addictions
Tarzana, California
Torrance Site
Torrance, California
University of Colorado Health Sciences Center
Denver, Colorado
John A. Burns School of Medicine
Honolulu, Hawaii
Powell Chemical Dependency Center
Des Moines, Iowa
START Research and Treatment
Kansas City, Missouri
Salt Lake City VA Medical Center
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.